ITMI921914A0 - Derivati peptidici ad attivita' citostimolante e citoprotettive - Google Patents

Derivati peptidici ad attivita' citostimolante e citoprotettive

Info

Publication number
ITMI921914A0
ITMI921914A0 IT92MI1914A ITMI921914A ITMI921914A0 IT MI921914 A0 ITMI921914 A0 IT MI921914A0 IT 92MI1914 A IT92MI1914 A IT 92MI1914A IT MI921914 A ITMI921914 A IT MI921914A IT MI921914 A0 ITMI921914 A0 IT MI921914A0
Authority
IT
Italy
Prior art keywords
cytostimulating
peptide derivatives
cytoprotective activities
cytoprotective
activities
Prior art date
Application number
IT92MI1914A
Other languages
English (en)
Inventor
Giancarlo Sportoletti
Pozzo Alma Dal
Original Assignee
Ellem Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Ind Farmaceutica filed Critical Ellem Ind Farmaceutica
Priority to ITMI921914A priority Critical patent/IT1261646B/it
Publication of ITMI921914A0 publication Critical patent/ITMI921914A0/it
Priority to EP93917672A priority patent/EP0656009A1/en
Priority to PCT/EP1993/002004 priority patent/WO1994003482A1/en
Priority to JP6504972A priority patent/JPH07509704A/ja
Priority to AU47033/93A priority patent/AU4703393A/en
Publication of ITMI921914A1 publication Critical patent/ITMI921914A1/it
Application granted granted Critical
Publication of IT1261646B publication Critical patent/IT1261646B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ITMI921914A 1992-08-04 1992-08-04 Derivati peptidici ad attivita' citostimolante e citoprotettiva IT1261646B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI921914A IT1261646B (it) 1992-08-04 1992-08-04 Derivati peptidici ad attivita' citostimolante e citoprotettiva
EP93917672A EP0656009A1 (en) 1992-08-04 1993-07-28 Glycyl-hystidyle-lysine (ghl) derivatives
PCT/EP1993/002004 WO1994003482A1 (en) 1992-08-04 1993-07-28 Glycyl-hystidyle-lysine (ghl) derivatives
JP6504972A JPH07509704A (ja) 1992-08-04 1993-07-28 グリシルーヒスチジルーリシン（ｇｈｌ）誘導体
AU47033/93A AU4703393A (en) 1992-08-04 1993-07-28 Glycyl-hystidyle-lysine (ghl) derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921914A IT1261646B (it) 1992-08-04 1992-08-04 Derivati peptidici ad attivita' citostimolante e citoprotettiva

Publications (3)

Publication Number Publication Date
ITMI921914A0 true ITMI921914A0 (it) 1992-08-04
ITMI921914A1 ITMI921914A1 (it) 1994-02-05
IT1261646B IT1261646B (it) 1996-05-28

Family

ID=11363826

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921914A IT1261646B (it) 1992-08-04 1992-08-04 Derivati peptidici ad attivita' citostimolante e citoprotettiva

Country Status (5)

Country Link
EP (1) EP0656009A1 (it)
JP (1) JPH07509704A (it)
AU (1) AU4703393A (it)
IT (1) IT1261646B (it)
WO (1) WO1994003482A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
FR2791684B1 (fr) * 1999-03-30 2001-05-11 Sederma Sa Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse
FR2802413B1 (fr) * 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
US20030148927A1 (en) * 2001-10-05 2003-08-07 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
JP2006504448A (ja) * 2002-07-02 2006-02-09 プロサイト コーポレイション ペプチド銅錯体および軟組織充填物を含有する組成物
US6927206B2 (en) 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
WO2006101855A2 (en) 2005-03-16 2006-09-28 Procyte Corporation Methods and compositions for preventing and treating aging or photodamaged skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
EP0288278B1 (en) * 1987-04-20 1994-03-30 Procyte Corporation Chemical derivatives of GHL-CU

Also Published As

Publication number Publication date
EP0656009A1 (en) 1995-06-07
ITMI921914A1 (it) 1994-02-05
IT1261646B (it) 1996-05-28
JPH07509704A (ja) 1995-10-26
WO1994003482A1 (en) 1994-02-17
AU4703393A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
ITMI920973A0 (it) Derivati di adenosina ad attivita' a2 agonista
ITMI932113A0 (it) Oligopeptidi ad attivita' fungicida
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
DE69223266T2 (de) Peptidderivate und deren Verwendung
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
ITMI913294A1 (it) Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
ITMI921914A0 (it) Derivati peptidici ad attivita' citostimolante e citoprotettive
ITTO920114A1 (it) Derivati bis-tetrazolici ad attivita' antiallergica e citoprotettiva
ITMI930819A0 (it) Derivati eterobiciclici ad attivita' fungicida
IT9019422A0 (it) Composizioni farmaceutiche ad attivita' depigmentante e "antiphotoaging"
ITMI941292A0 (it) Derivati peptidici ad attivita' inibitrice delle metallopeptidasi
DE69328467D1 (de) Polyamidzusammensetzung und Verwendung
ITMI921571A1 (it) Azaciclo e azabiciclo alchiliden idrossilamine
ITMI912422A0 (it) Derivati ossimici ad attivita' fungicida
ITMI942304A0 (it) Derivati fluorenil-idrossammici ad attivita' immunosoppressiva ed antiinfiammatoria
ITMI921950A1 (it) Composizioni farmaceutiche ad attivita' epato-trofica ed anti-aging
ITMI930422A0 (it) Derivati di indenopiridazioni e benzocinnolioni ad attivita' antitumorali
ITMI921423A1 (it) Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
ITMI921766A1 (it) Composti ad attivita' neuroprotettiva
ITRM920045A0 (it) Composizioni farmaceutiche ad attivita' anti-aging.
IT9019229A0 (it) Derivati ossimici ad attivita' fungicida
DE69405544T2 (de) 4'-0-sulfonylanthracyclinderivate
ITMI911344A1 (it) Associazione farmaceutica ad attivita' antineoplastica
FI924663A0 (fi) Liitoselementti ja sen käyttö
IT1282633B1 (it) Derivati polialogenoalchilici ad attivita' fungicida

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950830